United States: FTC Action Against Physician Cooperative Illustrates Risks of Collective Contracting Activity Among Independent Providers

A recent Federal Trade Commission ("FTC") enforcement action against a physician cooperative in Puerto Rico for organizing a group boycott of a health plan underscores the need for providers to be cognizant of the antitrust laws when engaging in group contracting efforts. The action, which resulted in a proposed consent order, illustrates that agreements among independent providers on the prices they will charge or payors they will deal with are generally per se illegal, though certain exceptions exist for financially or clinically integrated provider joint ventures.

The FTC Action Against OFTACOOP

The FTC charged that OFTACOOP (also known as Cooperativa de Médico Oftalmólogos de Puerto Rico), a Puerto Rico ophthalmologist cooperative with about 100 members, violated section 5 of the FTC Act by orchestrating an agreement among competing ophthalmologists to refuse to deal with a health plan, MCS Advantage, Inc., and its network administrator, Eye Management of Puerto Rico, LLC.

The complaint alleged that MCS asked Eye Management to create and manage a network of ophthalmologists in Puerto Rico in order to lower its costs after Medicare reduced its premiums. After MCS and Eye Management sent proposed contracts to individual doctors offering lower rates for the new network, OFTACOOP convened a meeting during which its member and non-member ophthalmologists agreed not to sign the new contracts. Shortly after the meeting, OFTACOOP also sent an email to more than 100 ophthalmologists with the subject line "DO NOT SIGN THE MCS/EYE MANAGEMENT AGREEMENT," which instructed them to refuse to sign the proposed contract so they could collectively negotiate with payors through OFTACOOP.

Despite a cease-and-desist letter from Eye Management's counsel warning of antitrust violations, OFTACOOP persisted in encouraging members to unite together to refuse to deal with Eye Management. As a result, Eye Management was unable to form an adequate network of ophthalmologists. The ophthalmologists then also refused to contract directly with MCS at lower rates, and many cancelled or threatened to cancel their existing contracts with MCS, forcing MCS to maintain its current reimbursement rates.

The FTC determined that the conduct was not reasonably related to achieving any efficiency-enhancing integration, and would unreasonably restrain competition and increase costs of ophthalmology services.

The proposed consent order, entered January 19, 2017, prohibits OFTACOOP from, among other things, organizing agreements to refuse to deal with payors or to deal only through OFTACOOP, and forbids information exchanges to facilitate that prohibited conduct. The public comment period closed last week and the consent order is expected to be made final shortly.

Financial and Clinical Integration

As the FTC noted in OFTACOOP, there are certain types of efficiency-enhancing integration, although not present in that case, which may justify pricing agreements among independent health care providers. A physician network joint venture that is appropriately integrated (financially or clinically) will not be condemned as per se illegal, but will instead be analyzed under the rule of reason – a more lenient standard that weighs pro-competitive benefits against anticompetitive harms.

Financial Integration

Provider joint ventures in which participants share substantial financial risk will qualify for rule of reason review and may also fall within an antitrust safety zone if they have sufficiently low market share – less than 30 percent of physicians in that specialty in the geographic market if the venture is non-exclusive, or less than 20 percent if exclusive. Antitrust law presumes that efficiencies will be created by arrangements that involve significant risk sharing (typically the risk is shared both among the providers in the venture and between the venture and the payor) because they provide incentives for physicians to control costs and better manage the provision of services. Examples of qualifying risk-sharing arrangements include capitation, agreements to provide services for a set percentage of revenue, incentive contracts that withhold and distribute compensation based on meeting group performance goals, and agreements to provide a course of treatment for a fixed amount.

Clinical Integration

Antitrust enforcement agencies have recognized that clinical integration may be evidenced by a "network implementing an active and ongoing program to evaluate and modify practice patterns by the network's physician participants and create a high degree of interdependence and cooperation among the physicians to control costs and ensure quality."1 Clinical integration often requires a significant investment of time and money to develop, implement and maintain.

The FTC, largely through a series of advisory opinions, has indicated its approval of clinical integration programs containing the following features:

  • Development and adoption of practice guidelines and protocols across a broad spectrum of diseases and conditions
  • Participation by a broad range of physicians and specialists
  • Significant personal investment of time and money by physicians
  • Technical infrastructure to support electronic information sharing
  • Mechanisms to monitor and enforce compliance with protocols and consequences for non-compliance
  • Allowance for non-exclusive, independent contracting so that physicians are free to join other networks and contract outside of the joint venture

The clinical integration venture must be able to not only identify efficiencies it will achieve, but to also explain why joint contracting is reasonably necessary to achieve those efficiencies. Some have successfully answered that question by pointing to the need to identify a stable network of physicians and facilitate in-network referrals.2 Ultimately, the program must be viable in the marketplace because it offers something of value to payors, not because it is collectively forced on them.

Antitrust analyses of provider joint conduct and integration are highly individualized and fact-specific, and should be carefully addressed with antitrust counsel. To discuss how these issues might impact you or your business, please contact one of the authors, or the Reed Smith attorney with whom you regularly work.

  1. Dep't of Justice & Federal Trade Comm'n, Statements Of Antitrust Enforcement Policy in Health Care (1996), § 8 (B)(1).
  2. See Norman PHO Advisory Opinion Letter (February 13, 2013) at 10.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.